These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 37821927

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Assessment of heart rate turbulence in dogs with myxomatous mitral valve disease.
    Dos Santos JP, Lucina SB, da Costa BN, Olaguivel KLC, Tuleski GLR, Sousa MG.
    Open Vet J; 2021; 11(4):635-644. PubMed ID: 35070858
    [Abstract] [Full Text] [Related]

  • 23. Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation.
    Häggström J, Hansson K, Karlberg BE, Kvart C, Madej A, Olsson K.
    Am J Vet Res; 1996 Nov; 57(11):1645-52. PubMed ID: 8915446
    [Abstract] [Full Text] [Related]

  • 24. Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) Study Group.
    Ettinger SJ, Benitz AM, Ericsson GF, Cifelli S, Jernigan AD, Longhofer SL, Trimboli W, Hanson PD.
    J Am Vet Med Assoc; 1998 Dec 01; 213(11):1573-7. PubMed ID: 9838955
    [Abstract] [Full Text] [Related]

  • 25. [Treatment of mitral valve insufficiency in dogs with the ACE inhibitor enalapril. A clinical progress study].
    Biller B, Hörauf A, Kraft W.
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 1998 Feb 01; 26(1):21-30. PubMed ID: 9531670
    [Abstract] [Full Text] [Related]

  • 26. Heart rate variability parameters of myxomatous mitral valve disease in dogs with and without heart failure obtained using 24-hour Holter electrocardiography.
    Oliveira MS, Muzzi RA, Araújo RB, Muzzi LA, Ferreira DF, Nogueira R, Silva EF.
    Vet Rec; 2012 Jun 16; 170(24):622. PubMed ID: 22645158
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Factors affecting the urinary aldosterone-to-creatinine ratio in healthy dogs and dogs with naturally occurring myxomatous mitral valve disease.
    Galizzi A, Bagardi M, Stranieri A, Zanaboni AM, Malchiodi D, Borromeo V, Brambilla PG, Locatelli C.
    BMC Vet Res; 2021 Jan 07; 17(1):15. PubMed ID: 33413406
    [Abstract] [Full Text] [Related]

  • 29. Effect of standard-dose and high-dose pimobendan on select indices of renal and cardiac function in dogs with American College of Veterinary Internal Medicine stage B2 myxomatous mitral valve disease.
    Kaplan JL, Visser LC, Gunther-Harrington CT, Ontiveros ES, Wittenburg LA, Palm CA, Stern JA.
    J Vet Intern Med; 2022 Nov 07; 36(6):1892-1899. PubMed ID: 36098206
    [Abstract] [Full Text] [Related]

  • 30. Survival and echocardiographic data in dogs with congestive heart failure caused by mitral valve disease and treated by multiple drugs: a retrospective study of 21 cases.
    de Madron E, King JN, Strehlau G, White RV.
    Can Vet J; 2011 Nov 07; 52(11):1219-25. PubMed ID: 22547843
    [Abstract] [Full Text] [Related]

  • 31. Short-Term Effects of Sacubitril/valsartan on Echocardiographic Parameters in Dogs With Symptomatic Myxomatous Mitral Valve Disease.
    Saengklub N, Pirintr P, Nampimoon T, Kijtawornrat A, Chaiyabutr N.
    Front Vet Sci; 2021 Nov 07; 8():700230. PubMed ID: 34386539
    [Abstract] [Full Text] [Related]

  • 32. Effect of atorvastatin on oxidative stress and inflammation markers in myxomatous mitral valve disease in dogs: A comparison of subclinical and clinical stages.
    Thassakorn P, Patchanee P, Pongkan W, Chattipakorn N, Boonyapakorn C.
    J Vet Pharmacol Ther; 2019 May 07; 42(3):258-267. PubMed ID: 30666669
    [Abstract] [Full Text] [Related]

  • 33. Mitral valve prolapse in Cavalier King Charles spaniel: a review and case study.
    Hyun C.
    J Vet Sci; 2005 Mar 07; 6(1):67-73. PubMed ID: 15785126
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of endothelial cell-specific molecule-1 as a biomarker of glycocalyx damage in canine myxomatous mitral valve disease.
    Hong HJ, Oh YI, Park SM, An JH, Kim TH, Chae HK, Seo KW, Youn HY.
    BMC Vet Res; 2022 Jul 05; 18(1):261. PubMed ID: 35790968
    [Abstract] [Full Text] [Related]

  • 35. Database development and survival analysis in a clinical and historical cohort of dogs affected by myxomatous mitral valve disease treated or not with pimobendan using causal inference techniques.
    Bagardi M, Palermo V, Locatelli C, Colombo FM, Pazzagli L, Brambilla PG.
    Vet Res Commun; 2022 Jun 05; 46(2):481-486. PubMed ID: 35034282
    [Abstract] [Full Text] [Related]

  • 36. Cardiorenal and endocrine effects of synthetic canine BNP1-32 in dogs with compensated congestive heart failure caused by myxomatous mitral valve disease.
    Yata M, Kooistra HS, Beijerink NJ.
    J Vet Intern Med; 2019 Mar 05; 33(2):462-470. PubMed ID: 30703246
    [Abstract] [Full Text] [Related]

  • 37. Serum Proteomic Profiles Reflect the Stages of Myxomatous Mitral Valve Disease in Dogs.
    Rešetar Maslov D, Farkaš V, Rubić I, Kuleš J, Beletić A, Beer Ljubić B, Šmit I, Mrljak V, Torti M.
    Int J Mol Sci; 2023 Apr 12; 24(8):. PubMed ID: 37108311
    [Abstract] [Full Text] [Related]

  • 38. Dietary intervention reduces left atrial enlargement in dogs with early preclinical myxomatous mitral valve disease: a blinded randomized controlled study in 36 dogs.
    Li Q, Heaney A, Langenfeld-McCoy N, Boler BV, Laflamme DP.
    BMC Vet Res; 2019 Nov 27; 15(1):425. PubMed ID: 31775756
    [Abstract] [Full Text] [Related]

  • 39. Symmetric dimethylarginine in dogs with myxomatous mitral valve disease at various stages of disease severity.
    Valente C, Guglielmini C, Domenech O, Contiero B, Zini E, Poser H.
    PLoS One; 2020 Nov 27; 15(9):e0238440. PubMed ID: 32870923
    [Abstract] [Full Text] [Related]

  • 40. Short-term melatonin supplementation decreases oxidative stress but does not affect left ventricular structure and function in myxomatous mitral valve degenerative dogs.
    Pongkan W, Piamsiri C, Dechvongya S, Punyapornwitthaya V, Boonyapakorn C.
    BMC Vet Res; 2022 Jan 07; 18(1):24. PubMed ID: 34996468
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.